{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:45Z","timestamp":1792788045266,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2023YFC2507102"],"award-info":[{"award-number":["2023YFC2507102"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["823B2001"],"award-info":[{"award-number":["823B2001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341064,82090010, 82090011"],"award-info":[{"award-number":["82341064,82090010, 82090011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["CIFMS2021-I2M-1-049"],"award-info":[{"award-number":["CIFMS2021-I2M-1-049"]}],"id":[{"id":"https:\/\/ror.org\/02drdmm93","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Haihe Laboratory of Cell Ecosystem Innovation Fund","award":["22HHXBSS00008 and 22HHKYZX0034"],"award-info":[{"award-number":["22HHXBSS00008 and 22HHKYZX0034"]}]},{"name":"State Key Laboratory Special Fund","award":["2060204"],"award-info":[{"award-number":["2060204"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08643-8","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:46:53Z","timestamp":1784281613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma proteomics and machine learning deliver non-invasive distinction between fibrotic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Yizhuo","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaochu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaping","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"8643_CR1","doi-asserted-by":"crossref","unstructured":"Ryerson CJ, Marinescu DC, Muller NL, Hague CJ, Murphy D, Churg A et al. Outcomes of a typical fibrotic hypersensitivity pneumonitis pattern on chest computed tomography. Am J Respir Crit Care Med. 2025;211(10):1802\u201310.","DOI":"10.1164\/rccm.202411-2215OC"},{"issue":"8","key":"8643_CR2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-2600(25)00129-8","volume":"13","author":"P Spagnolo","year":"2025","unstructured":"Spagnolo P, Guler SA, Chaudhuri N, Udwadia Z, Ses\u00e9 L, Kaul B, et al. Global epidemiology and burden of interstitial lung disease. Lancet Respiratory Med. 2025;13(8):739\u201355.","journal-title":"Lancet Respiratory Med"},{"issue":"3","key":"8643_CR3","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","volume":"202","author":"G Raghu","year":"2020","unstructured":"Raghu G, Remy-Jardin M, Ryerson CJ, Myers JL, Kreuter M, Vasakova M, et al. Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;202(3):e36\u201369.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"8643_CR4","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.5858\/arpa.2019-0628-RA","volume":"144","author":"A Churg","year":"2020","unstructured":"Churg A. Centrilobular Fibrosis in Fibrotic (Chronic) Hypersensitivity Pneumonitis, Usual Interstitial Pneumonia, and Connective Tissue Disease-Associated Interstitial Lung Disease. Arch Pathol Lab Med. 2020;144(12):1509\u201316.","journal-title":"Arch Pathol Lab Med"},{"key":"8643_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41379-021-00866-y","volume":"35","author":"A Churg","year":"2022","unstructured":"Churg A. Hypersensitivity pneumonitis: new concepts and classifications. Mod Pathol. 2022;35:15\u201327.","journal-title":"Mod Pathol"},{"key":"8643_CR6","doi-asserted-by":"crossref","unstructured":"Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N et al. ERS\/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung disease. Ann Rheum Dis. 2026;85(1):22\u201360.","DOI":"10.1016\/j.ard.2025.08.021"},{"issue":"2","key":"8643_CR7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/his.15311","volume":"86","author":"A Churg","year":"2025","unstructured":"Churg A, Poletti V, Ravaglia C, Matej R, Vasakova MK, Hornychova H, et al. Pathological features of connective tissue disease-associated interstitial lung disease in transbronchial cryobiopsies. Histopathology. 2025;86(2):260\u20137.","journal-title":"Histopathology"},{"key":"8643_CR8","doi-asserted-by":"crossref","unstructured":"El Agha E, Wygrecka M. State of the art in idiopathic pulmonary fibrosis. Cells. 2022;11(16).","DOI":"10.3390\/cells11162487"},{"issue":"10082","key":"8643_CR9","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet (London England). 2017;389(10082):1941\u201352.","journal-title":"Lancet (London England)"},{"issue":"4","key":"8643_CR10","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41379-019-0389-3","volume":"33","author":"JL Wright","year":"2020","unstructured":"Wright JL, Churg A, Hague CJ, Wong A, Ryerson CJ. Pathologic separation of idiopathic pulmonary fibrosis from fibrotic hypersensitivity pneumonitis. Mod Pathol. 2020;33(4):616\u201325.","journal-title":"Mod Pathol"},{"issue":"2","key":"8643_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s40265-015-0350-9","volume":"75","author":"ES Kim","year":"2015","unstructured":"Kim ES, Keating GM. Pirfenidone: a review of its use in idiopathic pulmonary fibrosis. Drugs. 2015;75(2):219\u201330.","journal-title":"Drugs"},{"issue":"22","key":"8643_CR12","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King Jr","year":"2014","unstructured":"King TE Jr., Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2083\u201392.","journal-title":"N Engl J Med"},{"issue":"3","key":"8643_CR13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.chest.2016.10.029","volume":"151","author":"J Morisset","year":"2017","unstructured":"Morisset J, Johannson KA, Vittinghoff E, Aravena C, Elicker BM, Jones KD, et al. Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis. Chest. 2017;151(3):619\u201325.","journal-title":"Chest"},{"issue":"22","key":"8643_CR14","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071\u201382.","journal-title":"N Engl J Med"},{"issue":"9","key":"8643_CR15","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.jaip.2022.06.031","volume":"10","author":"S S\u00e1nchez-D\u00edez","year":"2022","unstructured":"S\u00e1nchez-D\u00edez S, Munoz X, Ojanguren I, Romero-Mesones C, Espejo D, Villar A, et al. YKL-40 and KL-6 Levels in Serum and Sputum of Patients Diagnosed With Hypersensitivity Pneumonitis. J Allergy Clin Immunology: Pract. 2022;10(9):2414\u201323.","journal-title":"J Allergy Clin Immunology: Pract"},{"issue":"5","key":"8643_CR16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/thoraxjnl-2021-217693","volume":"77","author":"H Furusawa","year":"2022","unstructured":"Furusawa H, Peljto AL, Walts AD, Cardwell J, Molyneaux PL, Lee JS, et al. Common idiopathic pulmonary fibrosis risk variants are associated with hypersensitivity pneumonitis. Thorax. 2022;77(5):508\u201310.","journal-title":"Thorax"},{"issue":"5","key":"8643_CR17","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.12-2685","volume":"144","author":"ER Fern\u00e1ndez P\u00e9rez","year":"2013","unstructured":"Fern\u00e1ndez P\u00e9rez ER, Swigris JJ, Forss\u00e9n AV, Tourin O, Solomon JJ, Huie TJ, et al. Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest. 2013;144(5):1644\u201351.","journal-title":"Chest"},{"issue":"3","key":"8643_CR18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.chest.2022.06.013","volume":"162","author":"DC Marinescu","year":"2022","unstructured":"Marinescu DC, Raghu G, Remy-Jardin M, Travis WD, Adegunsoye A, Beasley MB, et al. Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis. Chest. 2022;162(3):614\u201329.","journal-title":"Chest"},{"issue":"4","key":"8643_CR19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.23736\/S0031-0808.20.04056-2","volume":"64","author":"M D\u2019Alessandro","year":"2022","unstructured":"D\u2019Alessandro M, Bergantini L, Cameli P, Landi C, Lanzarone N, Perrone A, et al. Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis. Panminerva Med. 2022;64(4):548\u201354.","journal-title":"Panminerva Med"},{"issue":"1","key":"8643_CR20","doi-asserted-by":"crossref","first-page":"2416788","DOI":"10.1016\/j.pulmoe.2024.01.002","volume":"31","author":"PC Mota","year":"2025","unstructured":"Mota PC, Soares ML, Ferreira AC, Santos RF, Rufo JC, Vasconcelos D, et al. Polymorphisms and haplotypes of TOLLIP and MUC5B are associated with susceptibility and survival in patients with fibrotic hypersensitivity pneumonitis. Pulmonology. 2025;31(1):2416788.","journal-title":"Pulmonology"},{"key":"8643_CR21","doi-asserted-by":"crossref","unstructured":"Bruzova M, Pavlova M, Matej R, Sterclova M, Vasakova M. Interstitial score and concentrations of IL-4R\u03b1, PAR-2, and MMP-7 in bronchoalveolar lavage fluid could be useful markers for distinguishing idiopathic interstitial pneumonias. Diagnostics (Basel). 2021;11(4).","DOI":"10.3390\/diagnostics11040693"},{"key":"8643_CR22","doi-asserted-by":"crossref","first-page":"745233","DOI":"10.3389\/fimmu.2021.745233","volume":"12","author":"T Zhang","year":"2021","unstructured":"Zhang T, Shen P, Duan C, Gao L. KL-6 as an Immunological Biomarker Predicts the Severity, Progression, Acute Exacerbation, and Poor Outcomes of Interstitial Lung Disease: A Systematic Review and Meta-Analysis. Front Immunol. 2021;12:745233.","journal-title":"Front Immunol"},{"key":"8643_CR23","doi-asserted-by":"crossref","first-page":"939175","DOI":"10.3389\/fgene.2022.939175","volume":"13","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Fang C, Sun Q, Dong Y. Relevance of RNA N6-Methyladenosine Regulators for Pulmonary Fibrosis: Implications for Chronic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis. Front Genet. 2022;13:939175.","journal-title":"Front Genet"},{"key":"8643_CR24","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.3389\/fimmu.2018.02328","volume":"9","author":"D Pilling","year":"2018","unstructured":"Pilling D, Gomer RH. The Development of Serum Amyloid P as a Possible Therapeutic. Front Immunol. 2018;9:2328.","journal-title":"Front Immunol"},{"issue":"6","key":"8643_CR25","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jhep.2016.02.029","volume":"64","author":"B Bottazzi","year":"2016","unstructured":"Bottazzi B, Inforzato A, Messa M, Barbagallo M, Magrini E, Garlanda C, et al. The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling. J Hepatol. 2016;64(6):1416\u201327.","journal-title":"J Hepatol"},{"issue":"6","key":"8643_CR26","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1021\/acsomega.0c06201","volume":"6","author":"C Zhang","year":"2021","unstructured":"Zhang C, Liu C, Qu Y, Cao Y, Liu R, Sun Y, et al. LC-MS-Based Qualitative Analysis and Pharmacokinetic Integration Network Pharmacology Strategy Reveals the Mechanism of Phlomis brevidentata H.W.Li Treatment of Pneumonia. ACS Omega. 2021;6(6):4495\u2013505.","journal-title":"ACS Omega"},{"key":"8643_CR27","doi-asserted-by":"crossref","first-page":"155955","DOI":"10.1016\/j.phymed.2024.155955","volume":"134","author":"W Liu","year":"2024","unstructured":"Liu W, Li J, Xu S, Wang Y, Li J, Wang S, et al. Phillyrin and its metabolites exert antipyretic effects by targeting the NAD(+) binding domain of GAPDH, MDH2 and IDH2. Phytomedicine: Int J phytotherapy phytopharmacology. 2024;134:155955.","journal-title":"Phytomedicine: Int J phytotherapy phytopharmacology"},{"key":"8643_CR28","doi-asserted-by":"crossref","first-page":"1777938","DOI":"10.3389\/fimmu.2026.1777938","volume":"17","author":"H Hu","year":"2026","unstructured":"Hu H, Dou D, Shang R, Luo R. Transcriptomic analysis reveals immune dysregulation and identifies key genes in ICU patients with severe ARDS. Front Immunol. 2026;17:1777938.","journal-title":"Front Immunol"},{"issue":"1","key":"8643_CR29","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1038\/s41467-022-31115-8","volume":"13","author":"E Andreano","year":"2022","unstructured":"Andreano E, Paciello I, Marchese S, Donnici L, Pierleoni G, Piccini G, et al. Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees. Nat Commun. 2022;13(1):3375.","journal-title":"Nat Commun"},{"issue":"1","key":"8643_CR30","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1038\/s41467-022-31259-7","volume":"13","author":"B Zhou","year":"2022","unstructured":"Zhou B, Zhou R, Tang B, Chan JF, Luo M, Peng Q, et al. A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge. Nat Commun. 2022;13(1):3589.","journal-title":"Nat Commun"},{"issue":"1","key":"8643_CR31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40246-017-0101-y","volume":"11","author":"K Wang","year":"2017","unstructured":"Wang K, Gao M, Yang M, Meng F, Li D, Lu R, et al. Transcriptome analysis of bronchoalveolar lavage fluid from children with severe Mycoplasma pneumoniae pneumonia reveals novel gene expression and immunodeficiency. Hum Genomics. 2017;11(1):4.","journal-title":"Hum Genomics"},{"key":"8643_CR32","doi-asserted-by":"crossref","first-page":"1573511","DOI":"10.3389\/fcimb.2025.1573511","volume":"15","author":"Y Chen","year":"2025","unstructured":"Chen Y, Yuan Y, Liu X, Li B, Meng L, Xiao Y, et al. Alterations in BCR heavy chain CDR3 repertoire characteristics in pediatric mycoplasma pneumoniae infection. Front Cell Infect Microbiol. 2025;15:1573511.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"8643_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12931-021-01791-z","volume":"22","author":"TM Maher","year":"2021","unstructured":"Maher TM, Bendstrup E, Dron L, Langley J, Smith G, Khalid JM, et al. Global incidence and prevalence of idiopathic pulmonary fibrosis. Respir Res. 2021;22(1):197.","journal-title":"Respir Res"},{"issue":"1","key":"8643_CR34","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s12890-024-03198-0","volume":"24","author":"Q Xu","year":"2024","unstructured":"Xu Q, Hu G, Lin Q, Wu M, Tang K, Zhang Y, et al. The association between testosterone, estradiol, estrogen sulfotransferase and idiopathic pulmonary fibrosis: a bidirectional mendelian randomization study. BMC Pulm Med. 2024;24(1):435.","journal-title":"BMC Pulm Med"},{"issue":"5","key":"8643_CR35","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1074\/mcp.RA117.000538","volume":"17","author":"M Kostas","year":"2018","unstructured":"Kostas M, Haugsten EM, Zhen Y, Sorensen V, Szybowska P, Fiorito E, et al. Protein Tyrosine Phosphatase Receptor Type G (PTPRG) Controls Fibroblast Growth Factor Receptor (FGFR) 1 Activity and Influences Sensitivity to FGFR Kinase Inhibitors. Mol Cell Proteom. 2018;17(5):850\u201370.","journal-title":"Mol Cell Proteom"},{"issue":"1","key":"8643_CR36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5603\/ARM.2020.0081","volume":"88","author":"WJ Piotrowski","year":"2020","unstructured":"Piotrowski WJ, Bestry I, Bia\u0142as AJ, Boros PW, Grzanka P, Jassem E, et al. Guidelines of the Polish Respiratory Society for diagnosis and treatment of idiopathic pulmonary fibrosis. Adv Respir Med. 2020;88(1):41\u201393.","journal-title":"Adv Respir Med"},{"issue":"1","key":"8643_CR37","first-page":"e242531","volume":"316","author":"L Chelala","year":"2025","unstructured":"Chelala L, Brixey AG, Hobbs SB, Kanne JP, Kligerman SJ, Lynch DA, et al. Curr State Fibrotic Interstitial Lung Disease Imaging Radiol. 2025;316(1):e242531.","journal-title":"Curr State Fibrotic Interstitial Lung Disease Imaging Radiol"},{"key":"8643_CR38","doi-asserted-by":"crossref","unstructured":"Fisher JH, Shapera S, To T, Marras TK, Gershon A, Dell S. Procedure volume and mortality after surgical lung biopsy in interstitial lung disease. Eur Respir J. 2019;53(2).","DOI":"10.1183\/13993003.01164-2018"},{"issue":"7","key":"8643_CR39","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1513\/AnnalsATS.201801-067OC","volume":"15","author":"SA Guler","year":"2018","unstructured":"Guler SA, Ellison K, Algamdi M, Collard HR, Ryerson CJ. Heterogeneity in Unclassifiable Interstitial Lung Disease. A Systematic Review and Meta-Analysis. Ann Am Thorac Soc. 2018;15(7):854\u201363.","journal-title":"Ann Am Thorac Soc"},{"issue":"9","key":"8643_CR40","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022;205(9):e18\u201347.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"8643_CR41","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1164\/rccm.201907-1343LE","volume":"201","author":"S Alqalyoobi","year":"2020","unstructured":"Alqalyoobi S, Adegunsoye A, Linderholm A, Hrusch C, Cutting C, Ma SF, et al. Circulating Plasma Biomarkers of Progressive Interstitial Lung Disease. Am J Respir Crit Care Med. 2020;201(2):250\u20133.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"8643_CR42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S2213-2600(21)00503-8","volume":"10","author":"WS Bowman","year":"2022","unstructured":"Bowman WS, Newton CA, Linderholm AL, Neely ML, Pugashetti JV, Kaul B, et al. Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis. Lancet Respiratory Med. 2022;10(6):593\u2013602.","journal-title":"Lancet Respiratory Med"},{"issue":"10","key":"8643_CR43","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1164\/rccm.202001-0134OC","volume":"202","author":"H Furusawa","year":"2020","unstructured":"Furusawa H, Cardwell JH, Okamoto T, Walts AD, Konigsberg IR, Kurche JS, et al. Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular Signatures. Am J Respir Crit Care Med. 2020;202(10):1430\u201344.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"8643_CR44","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1038\/s41467-021-24021-y","volume":"12","author":"A Doni","year":"2021","unstructured":"Doni A, Parente R, Laface I, Magrini E, Cunha C, Colombo FS, et al. Serum amyloid P component is an essential element of resistance against Aspergillus fumigatus. Nat Commun. 2021;12(1):3739.","journal-title":"Nat Commun"},{"issue":"9","key":"8643_CR45","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1371\/journal.ppat.0030120","volume":"3","author":"J Yuste","year":"2007","unstructured":"Yuste J, Botto M, Bottoms SE, Brown JS. Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae. PLoS Pathog. 2007;3(9):1208\u201319.","journal-title":"PLoS Pathog"},{"issue":"3","key":"8643_CR46","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1183\/13993003.00850-2015","volume":"47","author":"B van den Blink","year":"2016","unstructured":"van den Blink B, Dillingh MR, Ginns LC, Morrison LD, Moerland M, Wijsenbeek M, et al. Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy. Eur Respir J. 2016;47(3):889\u201397.","journal-title":"Eur Respir J"},{"issue":"4","key":"8643_CR47","doi-asserted-by":"crossref","first-page":"e93730","DOI":"10.1371\/journal.pone.0093730","volume":"9","author":"D Pilling","year":"2014","unstructured":"Pilling D, Gomer RH. Persistent lung inflammation and fibrosis in serum amyloid P component (APCs-\/-) knockout mice. PLoS ONE. 2014;9(4):e93730.","journal-title":"PLoS ONE"},{"key":"8643_CR48","doi-asserted-by":"crossref","first-page":"157727","DOI":"10.1016\/j.phymed.2025.157727","volume":"151","author":"M Jiang","year":"2026","unstructured":"Jiang M, Yang Y, Zhang Y, Zhang P, Zhang Q, Yang T, et al. Covalent targeting GAPDH by Pudilan formula and baicalein suppresses macrophage Warburg effect to alleviate acute lung injury. Phytomedicine: Int J phytotherapy phytopharmacology. 2026;151:157727.","journal-title":"Phytomedicine: Int J phytotherapy phytopharmacology"},{"issue":"1","key":"8643_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12929-022-00861-8","volume":"29","author":"PC Chen","year":"2022","unstructured":"Chen PC, Hsieh MH, Kuo WS, Wu LS, Kao HF, Liu LF, et al. Moonlighting glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein of Lactobacillus gasseri attenuates allergic asthma via immunometabolic change in macrophages. J Biomed Sci. 2022;29(1):75.","journal-title":"J Biomed Sci"},{"key":"8643_CR50","doi-asserted-by":"crossref","first-page":"157240","DOI":"10.1016\/j.phymed.2025.157240","volume":"147","author":"J Wu","year":"2025","unstructured":"Wu J, Li Y, Yang Y, Chen R, Wang H, Xie K, et al. Wogonoside inhibits fibroblast activation and pulmonary fibrosis by dual regulation of Snail1 lactylation and PGC1alpha\/PINK1-mediated mitophagy. Phytomedicine: Int J phytotherapy phytopharmacology. 2025;147:157240.","journal-title":"Phytomedicine: Int J phytotherapy phytopharmacology"},{"key":"8643_CR51","doi-asserted-by":"crossref","unstructured":"Issaian AV, Dzieciatkowska M, Bevers S, Safari Z, Hay AM, Cendali FI et al. The red blood cell proteome and interactome identify a Band 3-BLVRB axis regulating hypoxic metabolic adaptation. Blood. 2026.","DOI":"10.1182\/blood.2025032915"},{"issue":"3","key":"8643_CR52","doi-asserted-by":"crossref","first-page":"e70405","DOI":"10.1002\/mnfr.70405","volume":"70","author":"X Wang","year":"2026","unstructured":"Wang X, Liu Y, Zhou D, Liao Y, Ma X, Gong X, et al. Identification of GAPDH as an Allergen in Allium Mongolicum Regel and Its Pro-Inflammatory Effects on respiratory and Intestinal Epithelia. Mol Nutr Food Res. 2026;70(3):e70405.","journal-title":"Mol Nutr Food Res"},{"issue":"21","key":"8643_CR53","doi-asserted-by":"crossref","first-page":"14859","DOI":"10.1021\/acs.est.6c00422","volume":"60","author":"Q Song","year":"2026","unstructured":"Song Q, Ou Z, Wang Z, Liu J, Ye L, Jiang Y, et al. Exhaled Breath Condensate Reveals PM(2.5)-Driven Airway Metabolic Signature in Young Adults: A Panel Study. Environ Sci Technol. 2026;60(21):14859\u201372.","journal-title":"Environ Sci Technol"},{"issue":"1","key":"8643_CR54","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12967-025-07639-0","volume":"24","author":"J Luo","year":"2025","unstructured":"Luo J, Liu P, Song J, Li Y, Xu M. Bioavailable testosterone reduces the risk of lung squamous cell carcinoma: a comprehensive data study. J translational Med. 2025;24(1):118.","journal-title":"J translational Med"},{"issue":"11","key":"8643_CR55","doi-asserted-by":"crossref","first-page":"e3050","DOI":"10.7196\/SAMJ.2025.v115i11.3050","volume":"115","author":"MS Phuti","year":"2025","unstructured":"Phuti MS, Dalvie MA, Olaniyan T, Basera W, Jeebhay MF. The association between reproductive hormones and asthma-related outcomes in boys in the rural Western Cape Province, South Africa. S Afr Med J. 2025;115(11):e3050.","journal-title":"S Afr Med J"},{"issue":"1","key":"8643_CR56","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s10787-023-01409-4","volume":"32","author":"J Bai","year":"2024","unstructured":"Bai J, Zhang C, Liu Y, Kuang N, Xu L, Xu Z, et al. The therapeutic effect of Loranthus parasiticus lignan derivatives on collagen-induced arthritis in rats through the SHBG\/NF\u03baB pathway. Inflammopharmacology. 2024;32(1):873\u201383.","journal-title":"Inflammopharmacology"},{"issue":"1","key":"8643_CR57","doi-asserted-by":"publisher","first-page":"25095","DOI":"10.1038\/s41598-024-76526-3","volume":"14","author":"AJ Vazquez Cegla","year":"2024","unstructured":"Vazquez Cegla AJ, Jones KT, Cui G, Cottrill KA, Koval M, McCarty NA. Effects of hyperglycemia on airway epithelial barrier function in WT and CF 16HBE cells. Sci Rep. 2024;14(1):25095.","journal-title":"Sci Rep"},{"issue":"D1","key":"8643_CR58","doi-asserted-by":"crossref","first-page":"D1522","DOI":"10.1093\/nar\/gkab1081","volume":"50","author":"T Chen","year":"2022","unstructured":"Chen T, Ma J, Liu Y, Chen Z, Xiao N, Lu Y, et al. iProX in 2021: connecting proteomics data sharing with big data. Nucleic Acids Res. 2022;50(D1):D1522\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"8643_CR59","doi-asserted-by":"crossref","first-page":"D1211","DOI":"10.1093\/nar\/gky869","volume":"47","author":"J Ma","year":"2019","unstructured":"Ma J, Chen T, Wu S, Yang C, Bai M, Shu K, et al. iProX: an integrated proteome resource. Nucleic Acids Res. 2019;47(D1):D1211\u20137.","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08643-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08643-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08643-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:10:36Z","timestamp":1791987036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08643-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8643"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08643-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Institutional Ethics Committee of China-Japan Friendship Hospital, Beijing, China (No. 2017-25-1) and conducted in accordance with the principles of the Declaration of Helsinki. Baseline questionnaires and clinical data were collected after obtaining voluntary informed consent from all participants.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The word count for the abstract is 261. The word count for the text is 6230. The manuscript contains 4 figures and 1 table. The number of Supplementary materials is 5. The number of references is 60.","order":4,"name":"Ethics","label":"Other information","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1301"}}